EP2833905
Samsett sjúkdómsmeðferð með hýalúróníðasa og æxlismiðuðu taxani
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.3.2013EP published:
2.5.2018EP application number:
13715069.4
EP translation filed:
4.6.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
14.3.2033Expiry date:
14.3.2020
Title:
COMBINATION THERAPY WITH HYALURONIDASE AND A TUMOR-TARGETED TAXANE
Timeline
Today
15.3.2013EP application
2.5.2018EP Publication
4.6.2018Translation submitted
15.6.2018Registration published
14.3.2020Expires
Owner
Name:
Halozyme, Inc.Address:
11388 Sorrento Valley Road, 92121, San Diego, CA, US
Inventor
Name:
MANEVAL, Daniel, C.Address:
San Diego, CA, US
Name:
SHEPARD, H., MichaelAddress:
San Diego, CA, US
Name:
THOMPSON, Curtis, B.Address:
San Diego, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261686429 PDate:
4.4.2012Country:
US
Number:
201261714719 PDate:
16.10.2012Country:
US
Classification
Categories:
A61K 38/47, A61K 9/00, A61K 9/107, A61K 9/127, A61K 9/50, A61K 9/51, A61K 31/337, A61K 31/37, A61K 31/42, A61K 31/573, A61K 31/706, A61K 31/7068, A61K 31/7076, A61K 31/7088, A61K 45/06, A61K 47/56, A61K 47/60, A61K 47/64, A61P 35/00, C12N 9/06, C12N 9/26
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 21.3.2019
Expires: 14.3.2020
Payer: Árnason Faktor